Suppr超能文献

短RNA双链体不对称末端结构对RNA干扰活性及链选择的影响。

Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection.

作者信息

Sano Masayuki, Sierant Malgorzata, Miyagishi Makoto, Nakanishi Mahito, Takagi Yasuomi, Sutou Shizuyo

机构信息

Biotherapeutic Research Laboratory, National Institute of Advanced Industrial Science and Technology, Central 4, 1-1-1 Higashi, Tsukuba, Ibaraki 305-8562, Japan.

出版信息

Nucleic Acids Res. 2008 Oct;36(18):5812-21. doi: 10.1093/nar/gkn584. Epub 2008 Sep 9.

Abstract

Short interfering RNAs (siRNAs) are valuable reagents for sequence-specific inhibition of gene expression via the RNA interference (RNAi) pathway. Although it has been proposed that the relative thermodynamic stability at the 5'-ends of siRNAs plays a crucial role in siRNA strand selection, we demonstrate here that a character of the 2-nt 3'-overhang of siRNAs is the predominant determinant of which strand participates in the RNAi pathway. We show that siRNAs with a unilateral 2-nt 3'-overhang on the antisense strand are more effective than siRNAs with 3'-overhangs at both ends, due to preferential loading of the antisense strand into the RNA-induced silencing complex (RISC). Regardless of the relative thermodynamic stabilities at the ends of siRNAs, overhang-containing strands are predominantly selected as the guide strand; whereas, relative stability markedly influences opposite strand selection. Moreover, we show that sense strand modifications, such as deletions or DNA substitutions, of siRNAs with unilateral overhang on the antisense strand have no negative effect on the antisense strand selection, but may improve RNAi potency. Our findings provide useful guidelines for the design of potent siRNAs and contribute to understanding the crucial factors in determining strand selection in mammalian cells.

摘要

短干扰RNA(siRNA)是通过RNA干扰(RNAi)途径对基因表达进行序列特异性抑制的重要试剂。尽管有人提出siRNA 5'端的相对热力学稳定性在siRNA链选择中起关键作用,但我们在此证明,siRNA的2个核苷酸3'端悬垂的特征是决定哪条链参与RNAi途径的主要因素。我们表明,反义链上具有单侧2个核苷酸3'端悬垂的siRNA比两端都具有3'端悬垂的siRNA更有效,这是因为反义链优先加载到RNA诱导沉默复合体(RISC)中。无论siRNA末端的相对热力学稳定性如何,含悬垂的链主要被选为引导链;而相对稳定性则显著影响相反链的选择。此外,我们表明,反义链上具有单侧悬垂的siRNA的正义链修饰,如缺失或DNA替代,对反义链选择没有负面影响,但可能提高RNAi效力。我们的发现为高效siRNA的设计提供了有用的指导原则,并有助于理解哺乳动物细胞中决定链选择的关键因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ae9/2566866/88b707109fc0/gkn584f1.jpg

相似文献

1
Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection.
Nucleic Acids Res. 2008 Oct;36(18):5812-21. doi: 10.1093/nar/gkn584. Epub 2008 Sep 9.
3
Potent RNAi by short RNA triggers.
RNA. 2008 Sep;14(9):1714-9. doi: 10.1261/rna.1161908. Epub 2008 Jul 24.
5
Gene-silencing potency of symmetric and asymmetric lipid-conjugated siRNAs and its correlation with dicer recognition.
Bioconjug Chem. 2013 Dec 18;24(12):2045-57. doi: 10.1021/bc400391n. Epub 2013 Dec 9.
7
Recognition of siRNA asymmetry by TAR RNA binding protein.
Biochemistry. 2010 Apr 13;49(14):3148-55. doi: 10.1021/bi902189s.
8
Effect of siRNA with an asymmetric RNA/dTdT overhang on RNA interference activity.
Nucleic Acid Ther. 2014 Oct;24(5):364-71. doi: 10.1089/nat.2014.0494.
9
Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells.
Nucleic Acids Res. 2003 Jun 1;31(11):2705-16. doi: 10.1093/nar/gkg393.

引用本文的文献

1
2
RNA Therapeutics: Bridging Discovery and Clinical Implementation.
Methods Mol Biol. 2025;2965:1-37. doi: 10.1007/978-1-0716-4742-4_1.
3
RNAi-based drug design: considerations and future directions.
Nat Rev Drug Discov. 2024 May;23(5):341-364. doi: 10.1038/s41573-024-00912-9. Epub 2024 Apr 3.
4
Designing Nanomedicines for Breast Cancer Therapy.
Biomolecules. 2023 Oct 22;13(10):1559. doi: 10.3390/biom13101559.
5
RNA-based medicine: from molecular mechanisms to therapy.
EMBO J. 2023 Nov 2;42(21):e114760. doi: 10.15252/embj.2023114760. Epub 2023 Sep 20.
6
Chemistry, structure and function of approved oligonucleotide therapeutics.
Nucleic Acids Res. 2023 Apr 11;51(6):2529-2573. doi: 10.1093/nar/gkad067.
8
Specificity of oligonucleotide gene therapy (OGT) agents.
Theranostics. 2022 Oct 9;12(16):7132-7157. doi: 10.7150/thno.77830. eCollection 2022.
9
Chemical strategies for strand selection in short-interfering RNAs.
RSC Adv. 2021 Jan 11;11(4):2415-2426. doi: 10.1039/d0ra07747j. eCollection 2021 Jan 6.
10
Optimization in Chemical Modification of Single-Stranded siRNA Encapsulated by Neutral Cytidinyl/Cationic Lipids.
Front Chem. 2022 Mar 7;10:843181. doi: 10.3389/fchem.2022.843181. eCollection 2022.

本文引用的文献

1
Structural determinants of RNA recognition and cleavage by Dicer.
Nat Struct Mol Biol. 2007 Oct;14(10):934-40. doi: 10.1038/nsmb1293. Epub 2007 Sep 16.
2
Improved silencing properties using small internally segmented interfering RNAs.
Nucleic Acids Res. 2007;35(17):5886-97. doi: 10.1093/nar/gkm548. Epub 2007 Aug 28.
3
Sorting of Drosophila small silencing RNAs.
Cell. 2007 Jul 27;130(2):299-308. doi: 10.1016/j.cell.2007.05.057.
5
Molecular basis for target RNA recognition and cleavage by human RISC.
Cell. 2007 Jul 13;130(1):101-12. doi: 10.1016/j.cell.2007.04.037.
6
A systematic analysis of the effect of target RNA structure on RNA interference.
Nucleic Acids Res. 2007;35(13):4322-30. doi: 10.1093/nar/gkm437. Epub 2007 Jun 18.
7
RNA helicase A interacts with RISC in human cells and functions in RISC loading.
Mol Cell. 2007 May 25;26(4):523-37. doi: 10.1016/j.molcel.2007.04.016.
8
The role of PACT in the RNA silencing pathway.
EMBO J. 2006 Feb 8;25(3):522-32. doi: 10.1038/sj.emboj.7600942. Epub 2006 Jan 19.
9
Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.
Cell. 2005 Nov 18;123(4):631-40. doi: 10.1016/j.cell.2005.10.022. Epub 2005 Nov 3.
10
Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes.
Cell. 2005 Nov 18;123(4):607-20. doi: 10.1016/j.cell.2005.08.044. Epub 2005 Nov 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验